Fisetin in Mild Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Alzheimer s Disease · Alzheimer Dementia · Alzheimer Dementia (AD) · Alzheimer Disease · Mild Cognitive Disorder · Neurocognitive Disorders, Mild · Neurocognitive Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Sunnybrook Research Institute, Toronto, Ontario, Canada

    Study coordinator · memoryresearch@sunnybrook.ca
    Contact: Principal Investigator (Krista Lanctôt, PhD)
Study leads
  • Krista Lanctôt, PhD

    Principal Investigator

    Sunnybrook Research Institute